Related Experiment Video
Updated: Jan 22, 2026

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
Published on: July 25, 2014
Durable Response in Histiocytic Sarcoma After Allogeneic Stem Cell Transplantation: A Case Report
Stefania Oliva1, Jessica Gill1,2, Elia Boccellato2
1Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, 10126 Torino, Italy.
Histiocytic sarcoma (HS), a rare cancer, is challenging to diagnose and treat. Allogeneic hematopoietic stem cell transplantation (HSCT) offers a curative option, even after initial partial response to chemotherapy.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Histiocytic sarcoma (HS) is a rare, aggressive malignancy with poor prognosis.
- Diagnosis and treatment are complicated by unclear pathogenesis and limited therapeutic data.
- Co-occurrence with hemophagocytic lymphohistiocytosis (HLH) presents additional management challenges.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:22Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Related Concept Videos
Induced Pluripotent Stem Cells
Brick Durability, Strength, and Appearance
Adult Stem Cells
Embryonic Stem Cells
Data Reporting and Recording
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...